The U.S. Department of State, Office of Global Partnerships (E/GP) welcomes concept paper submissions for the FY 2020 Fund for partnerships supporting COVID-19 relief efforts around the world.
The Fund will leverage private sector contributions, technology and innovations, and pivot The Department of State’s approach to how we provide technical assistance to scale up readiness and response operations in emerging markets and developing countries.
NSF welcomes proposals on behalf of all qualified scientists, engineers and educators. The Foundation strongly encourages women, minorities and persons with disabilities to participate fully in its programs. In accordance with Federal statutes, regulations and NSF policies, no person on grounds of race, color, age, sex, national origin or disability shall be excluded from participation in, be denied the benefits of, or be subjected to discrimination under, any program or activity receiving financial assistance from...
USAID/GH is seeking Concept Papers that incorporate interventions that will build upon and expand USAID's efforts to better connect communities and health systems, as part of the COVID-19 response as well as in strengthening and adapting existing health systems to their communities for COVID-19 preparedness and response
The purpose of this Notice of Special Interest is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation:
Research applications addressing these topics are considered responsive; not all topics are expected within the same application. Applications will be directed to the National Center for Medical Rehabilitation Research (NCMRR) at NICHD.
This letter invites Rapid Response Research (RAPID) and EArly-concept Grants for Exploratory Research (EAGER) proposals for research to clarify lessons from the COVID-19 pandemic for international collaboration and research to strengthen international collaboration in the future. Proposals must focus on research topics unique to international engagement. Proposals should be submitted by institutions eligible to submit proposals to NSF and must include international collaboration as an integral part of the work. NSF encourages proposals from diverse teams. Proposals from early career investigators are especially welcome.
This NOSI seeks to support investigation into the factors and molecular mechanisms that address the heterogeneity dictated by the host resilience. Research on general host responses to injurious challenges and their effects on lung function as well as mechanisms that impact susceptibility to ARDS is not considered to be responsive to this announcement.
The Pennsylvania Department of Health is expected to release a request for proposals to fund collaborative research projects that are consistent with the research priority of The COVID-19 Pandemic in Pennsylvania. Due to the short turnaround time expected between release of the RFP and the submission deadline for the full proposal, the Office of Limited Submissions is running this MANDATORY Notice of Intent. If a downselect is necessary those who have submitted their NOI will be notified and will need to provide the internal application materials listed below in a downselect competition due 5-7 days after the final RFP is published (expected early October).
The four main areas for financing in this call will include:
As a part of our SOS African Wildlife initiative, we are inviting proposals for Rapid Action Grants targeting terrestrial or freshwater threatened species in continental Sub-Saharan Africa and Madagascar. They are designed to enable immediate responses to threats linked to the COVID-19 crisis and its consequences.
The purpose of this award is to support research to understand and eliminate inequities in cancer care, specifically related to differential outcomes experienced by women from underserved or marginalized populations with gynecologic cancer, as well as to increase representation of underrepresented groups in gynecologic oncology as a strategy to achieve health equity for underserved women. Those eligible for applying are those who propose a study focused on a marginalized group, or those who identify as being from an under-represented group within the field of research.
This research project will focus on the gut microbiome and biological therapeutic interactions in an inflammatory context. The project will also initiate a project concerning gut microbiome and SARS-CoV-2, with screening of the gut microbiome of animal along their immunologic responses.
Applicants can either apply to the Pipeline Grants (11/4 deadline) or our regular research grants (11/11 deadline), but not both.
The Office of Foundation Relations is available to consult on proposal narrative elements and answer other foundation-related questions. Please contact Adrienne Krasowitz, (ajk68@psu.edu) for additional support. View Letter of Intent
In connection with our overall commitment to supporting frontline healthcare workers amid the COVID-19 pandemic, Johnson & Johnson is proud to continue the Nurses Innovate QuickFire Challenges series with a new challenge inspired by the NurseHack4Health: COVID-19 Virtual Hackathon where over 500 nurses, healthcare professionals, and tech enthusiasts convened virtually to help ideate potential solutions for COVID-19 health challenges. This QuickFire Challenge is open to all nurse innovators, and aims to help nurture early-stage ideas from the frontlines of COVID-19 by celebrating, supporting, & mentoring the nurse innovators behind them.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Up to two innovators with the best ideas aiming to address and enable potential healthcare solutions in the post-COVID era will receive up to KRW150,000,000 (approximately US$125,000[1]) in grant funding, residency at the Seoul Bio Hub, and mentorship and coaching from experts at the Johnson & Johnson Family of Companies.
Please Note: While there is no limit to the number of applications from any institution or organization, this submission process has been set up to evaluate applications to ensure congruence with the aims of the RFP. Please contact the following to discuss: Jess Kiely, Associate Director of Corporate and Foundation Relations, for College of Medicine applicants and for all others Sophie Penney, Director of Foundation Relations.
The Social Science Research Council (SSRC), as part of its Just Tech program, seeks proposals from across the social sciences and related fields that address the risks, opportunities, and challenges posed by public health surveillance stemming from the Covid-19 pandemic. We specifically encourage proposals that interrogate the role the public and private sectors may play in mitigating or exacerbating the health crisis, the effects of which are already unevenly distributed.
NIH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). This emergency FOA from the National Institutes of Health (NIH) provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative. The goal of the RADx-rad initiative is to encourage the development of novel, non-traditional approaches to identify the current SARS-CoV-2 virus or other markers of the COVID-19 disease that can be used in future outbreaks of COVID-19 and that could be applicable to other, as yet unknown, viruses. Specifically, the goal of this FOA is to solicit applicationsto enhance the utility of chemosensory testing as a COVID-19 screening tool by using objective tests to examine the onset and prognostic value of chemosensory loss and to encourage the development and/or deployment of home-based and on-site chemosensory tests. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.
Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed.
The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19). This emergency FOA provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative. Specifically, this FOA seeks to use technologies developed for single extracellular vesicle, exosome, and extracellular RNA (exRNA) isolation and analysis and reposition them for the detection of SARS-CoV-2. The funding for this initiative is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.
The goal of this RFA is to solicit Direct to Phase II SBIR applications to advance development of novel, non-traditional, safe and effective biosensing and detection approaches to identify the current SARS-CoV-2 virus or other biomarkers of the COVID-19 disease for use in outbreaks of COVID-19, as well as for use in future pandemics resulting from unknown viruses.
This FOA invites applications to pursue development and validation studies of COVID-19 surveillance methods, not based or focused on direct viral testing of individuals, in settings and institutions, including residential, with a high density of individuals who are together for prolonged periods of time. There are numerous promising technologies which could allow for multimodal surveillance inputs. However, these technologies are often not interoperable, not optimized for integration to increase robustness and not tested for general applicability to public health or for the specific need of high-risk population surveillance. Applications are invited that translate a combination of digital surveillance modalities into platforms that can assist the professional staff of high-risk facilities in making clinically meaningful care recommendations for patients at risk of COVID-19 or other respiratory viruses. Projects proposed may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate.
This FOA seeks to support innovative research to develop novel, new or unique and non-traditional approaches (e.g. diagnostic and prognostic biomarkers and/or biosignatures) to identify and characterize the spectrum of SARS CoV-2 associated illness, including the multisystem inflammatory syndrome in children (MIS-C) and, through a prognostic algorithm, predict the longitudinal risk of disease severity after a child is exposed to and may be infected with SARS-CoV-2 to properly tailor his or her management and optimize health outcomes.
NIH is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).This emergency funding opportunity announcement (FOA) from the National Institutes of Health (NIH) provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) project.
Research in response to this FOA can be proposed to address any aspect of wastewater-based testing, including but not limited to the following: 1) investigation of specific approaches aiming to inform and optimize wastewater sample collection, 2) demonstration and optimization of wastewater sample analysis approaches, 3) development of optimized intervention strategies, and 4) incorporation of computational, statistical, and mathematical models.
The National Institutes of Health (NIH) is issuing this funding opportunity announcement (FOA) in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS),for 2019 Novel Coronavirus (COVID-19). This emergency FOA from the National Institutes of Health (NIH) provides an expedited funding mechanism as part of the Rapid Acceleration of Diagnostics-Radical (RADx-rad) initiative.
Specifically, this FOA is seeking applications for a portable sensing device to detect volatile organic compounds (VOCs, i.e., scents or odors) emanating from skin or exhaled breath, saliva and different oral tissues from the oral cavity. These sensing devices must be able to associate VOC patterns to patients with symptomatic and asymptomatic COVID-19. These devices are expected to actively detect VOCs from skin and oral cavities of COVID-19 patients, without being invasive, or affecting the integrity of the skin and oral cavity.
Specifically, this FOA seeks to fund a single cooperative agreement for a RADx-rad Data Coordination Center (DCC) to serve as a communication center and data hub for RADx-rad awardees.
The purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The therapeutic agent must have already completed at least a Phase I clinical trial for a different indication, and not require additional regulatory studies for the new indication prior to starting a clinical trial.
The U.S. Department of State, Office of Global Partnerships (E/GP) is pleased to announce the COVID-19 Private Sector Engagement & Partnership Fund (Fund) Annual Program Statement (APS) that will be used make assistance awards.. This APS is being done in partnership the U.S. Agency for International Development and concept papers may be transferred to the Agency based upon a determination of suitability for award and administration. USAID’s policies and procedures will apply to concept papers that are transferred to the Agency. This APS utilizes a two-step process. Applicants must first submit a concise (5-page) concept paper designed to clearly communicate their program idea and objectives. This is not a full proposal. The purpose of the concept paper is to allow applicants to submit program ideas for evaluation prior to requiring the development of a full proposal application. After merit review of eligible concept papers, selected applicants will be invited to expand on their program idea(s) by submitting a full proposal application. Full proposals will go through a second merit review before a final funding decision is made. E/GP has outlined the process through which potential applicants may apply in Appendix 1 to this APS.
This RFP is soliciting proposals for investigator-sponsored research focused on investigating BMS marketed and investigational therapies as potential treatments for COVID-19. Please refer to BMS pipeline for more information.
This project was identified as a high priority research need from WRF’s International Water Research Summit on Environmental Surveillance of COVID-19 Indicators held on April 27th and April 30th, 2020. The other research needs stemming from the summit include: 1. Interlaboratory Methods assessment helping to establish a standard for detection of the SARS-CoV-2 signal in wastewater (Project 5089). 2. Impact of Storage and Pre-Treatment Methods on Signal Strength of SARS-CoV-2 Genetic Signal in Wastewater (Upcoming WRF Project).
XPRIZE Rapid Covid Testing is a $5 million dollar, 6-month competition to develop faster, cheaper, and easier to use COVID-19 testing methods at scale. No more guessing. No more lack of tests. The world needs more high-quality, affordable testing to safely re-open.
The COVID-19 Early Treatment Fund (CETF) was created to ensure rapid and successful completion of outpatient clinical trials for effective early treatments for COVID-19, using existing drugs. It’s a bold new approach that offers the shortest path to saving lives. We know that viruses are best treated with antivirals soon after infection. There are existing drugs, including antivirals, that experts believe have the potential to treat COVID-19. These medicines are an untapped resource that could help millions, keeping people out of hospitals and saving lives.
The National Council on Disability (NCD) seeks proposals for a cooperative agreement to develop NCD’s annual progress report which will examine COVID-19’s broadscale impacts on the lives of people with disabilities in seven major areas: nondiscriminatory access to healthcare; the direct care workforce; group housing; education; employment; mental health; and communications. The report will also include a discussion of the intersection of disability and race, and of transportation impacts. The research and findings in this report will provide policymakers, including the White House and Congress, and federal agencies, with insight needed to make policy decisions to improve the current and future welfare of people with disabilities in a national emergency like the COVID-19 pandemic. The report will also provide people with disabilities information on federal policy, legislation, and initiatives related to emergency preparedness and response.
BSAC announced an open call for funding to support grant applications in response to the current coronavirus (COVID-19) public health emergency.
This was a worldwide open call for research grant applications on all aspects of COVID-19 from all countries, with specific interest in expressions of interest from (a) researchers in low-to-middle-income countries, or applications that address aspects of COVID-19 in LMIC communities and (b) that address the impact of COVID-19 on the antimicrobial resistance and antimicrobial stewardship agenda.
Launched in response to AHRC’s Boundless Creativity campaign, the Joint Research Project will see the creation of an Expert Advisory Panel that will bring together leaders from across the arts, cultural, creative and HEI sectors, to guide, review and report on the subsequent findings to provide an evidence base that informs cultural recovery, renewal and future growth, and makes recommendations for future actions.
If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 14 days. If we approve the grant, you'll receive payment as quickly as your university can receive it.
Genentech and The Genentech Foundation are accepting letters of interest from prospective partners working to build a more diverse and inclusive future of healthcare and science. From kindergarten to career, we partner with organizations that equip students with financial and nonfinancial support, connect young professionals with mentors, and prepare young people to become leaders in science and medicine. We are excited to expand our work with new partners and will invite full proposals following our evaluation of the letters of interest.
Genentech and The Genentech Foundation are accepting letters of interest from prospective partners working to build a more diverse and inclusive future of healthcare and science. From kindergarten to career, we partner with organizations that equip students with financial and nonfinancial support, connect young professionals with mentors, and prepare young people to become leaders in science and medicine. We are excited to expand our work with new partners and will invite full proposals following our evaluation of the letters of interest.
The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be the quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. They should focus on the determinants and interactions of transmission among any host species, including but not limited to humans, non-human animals, and/or plants. This includes, for example, the spread of pathogens; the influence of environmental factors such as climate; the population dynamics and genetics of reservoir species or hosts; the feedback between ecological transmission and evolutionary dynamics; and the cultural, social, behavioral, and economic dimensions of pathogen transmission.
The Centers for Disease Control and Prevention provides support for domestic and global infrastructure to prevent and control infectious diseases that threaten the public’s health. The proposed cooperative agreement would fund organizations that represent professionals at the front line of preventing and controlling the spread of emerging and re-emerging infectious disease threats such as COVID-19, including clinicians, other healthcare professionals, healthcare systems, and other organizations and institutions responsible for infectious disease prevention and control in the United States.